- E-mail : info@wellonapharma.com
- Call : +91-261-2571244
- Mob: +91-7490041245
Glipizide is an ATP-dependent K+ channels blocker in pancreatic β cells and brain GABA containing neurons resulting in insulin release.
Glipizide is an oral rapid- and short-acting anti-diabetic medication from the sulfonylurea class. It is classified as a second-generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.
Specification:
|
Tests |
Specifications |
Results |
|
Appearance |
White or almost white crystalline powder |
White crystalline powder |
|
Identification |
IR: The IR absorption spectrum of sample corresponds to that of reference one |
Complies |
|
Loss on drying |
Not more than 0.5% |
0.1% |
|
Residue on ignition |
Not more than 0.2% |
0.03% |
|
Related substances Impurity A Impurity X3 Unspecified impurity Total impurities |
Not more than 0.3% Not more than 0.15% Not more than 0.10% Not more than 0.5% |
0.10% 0.08% 0.04% 0.26% |
|
Impurity B |
Not more than 0.01% |
N.D |
|
Assay |
98.0%~102.0% ( Calculated on dried basis) |
99.4% |
|
Conclusion |
Complies with BP |
|
Packaging details:
|
Packaging details: |
25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum. |
|
Storage: |
Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat |
|
Shelf Life: |
5 years if sealed and store away from direct sun light. |
